The generic name for the drug compound developed by Novo Nordisk
Other targets/mechanisms must therefore be considered
There are currently two billion adults, or approximately 30% of the world population, who are overweight or obese
10.3390/antiox10030414 Summary Keywords semaglutide, inflammation, C-reactive protein, glucagon-like peptide-1 receptor agonists, meta-analysis Citation Masson W, Lobo M, Nogueira JP, Rodriguez-Granillo AM, Barbagelata LE and Siniawski D (2024) Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis
Research has shown that a 4mm needle is sufficient to reach this layer in the vast majority of adults, regardless of their Body Mass Index (BMI)